In this proposal, we plan to do a combination of basic and clinical studies aimed at better understanding of surfactant therapy of Respiratory Distress Syndrome of premature infants. 1. Surfactant proteins will be isolated and used to make simple protein/lipid surfactant mixtures. These mixtures will be tested by electron spin resonance spectroscopy, measurement of surface tension, and assessment of biological effects in animal models of surfactant deficiency. These studies will indicate how lipid and surfactant proteins interact at a molecular level and the consequences of this interaction on surfactant function in vitro and in vivo. 2. Using isolated surfactant proteins, we will use sensitive enzyme-linked imunosorbent assays to measure the major surfactant proteins in tracheal aspirates taken from the infants treated with surfactant. Using other ELISA's for protein inhibitors of surfactant function, we will test whether surfactant protein/inhibitor ratios measured on sequential tracheal aspirates correlate with response to surfactant therapy and results of pulmonary function testing. 3. We will carry out a series of clinical studies using protocols designed to investigate improved strategies for surfactant therapy of RDS. Infants will be studied by serial tests of functional residual capacity, conductance, time constants, compliance, and gas exchange. Serial measurements will be done to assess left to right shunting through a patient ductus arteriosus. We will define which infants are most likely to respond to treatment, which factors are associated with a suboptimal clinical responses, and which biochemical or physiological tests are most helpful in predicting responses. These studies should increase our understanding of this promising new therapy for premature infants.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040666-03
Application #
3357939
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1988-09-01
Project End
1992-02-29
Budget Start
1990-09-01
Budget End
1992-02-29
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Boncuk, P; Kaser, M; Yu, Y et al. (1997) Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo. Lipids 32:247-53
Kaser, M R; Skouteris, G G (1997) Inhibition of bacterial growth by synthetic SP-B1-78 peptides. Peptides 18:1441-4
Gordon, L M; Horvath, S; Longo, M L et al. (1996) Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci 5:1662-75
Waring, A J; Faull, K F; Leung, C et al. (1996) Synthesis, secondary structure and folding of the bend region of lung surfactant protein B. Pept Res 9:28-39
Bruni, R; Fan, B R; David-Cu, R et al. (1996) Inactivation of surfactant in rat lungs. Pediatr Res 39:236-40
Findlay, R D; Taeusch, H W; David-Cu, R et al. (1995) Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants. Pediatr Res 37:26-30
Putz, G; Goerke, J; Schurch, S et al. (1994) Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol 76:1417-24
Sehgal, S S; Ewing, C K; Richards, T et al. (1994) Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc 86:46-52
Putz, G; Goerke, J; Clements, J A (1994) Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble. J Appl Physiol 77:597-605
Putz, G; Goerke, J; Taeusch, H W et al. (1994) Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J Appl Physiol 76:1425-31

Showing the most recent 10 out of 23 publications